Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone

被引:0
作者
Takashi Omoto
Junichi Asaka
Satoru Nihei
Kenzo Kudo
机构
[1] Iwate Medical University Hospital,Department of Pharmacy
[2] Iwate Medical University,Department of Clinical Pharmaceutics, School of Pharmacy
来源
Supportive Care in Cancer | 2023年 / 31卷
关键词
Opioid; Opioid-induced neurotoxicity; Risk factor analysis; Cancer patient; Elderly;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 170 条
[1]  
Van den Beuken-van Everdingen MH(2007)Prevalence of pain in patients with cancer: a systematic review of the past 40 years Ann Oncol 18 1437-1449
[2]  
De Rijke JM(2016)Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review J Pain Res 9 515-534
[3]  
Kessels AG(2018)Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review BMJ Support Palliat Care 8 117-128
[4]  
Schouten HC(2020)Oxycodone versus morphine for cancer pain titration: a systematic review and pharmacoeconomic evaluation PLoS One 15 e0231763-1584
[5]  
Van Kleef M(2014)Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients Support Care Cancer 22 1579-256
[6]  
Patijn J(2003)Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review J Pain 4 231-iv191
[7]  
Carlson CL(2018)Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines Ann Oncol 29 iv166-1704
[8]  
Schmidt-Hansen M(2018)Frequency, outcomes, and associated factors for opioid-induced neurotoxicity in patients with advanced cancer receiving opioids in inpatient palliative care J Palliat Med 21 1698-220
[9]  
Bennett MI(2013)Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids Oncologist 18 212-856
[10]  
Arnold S(2019)Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database Support Care Cancer 27 849-1191